Phibro Animal Health Corporation Class A Stock News

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Barclays Annual Global Healthcare Conference. Chief Financial Officer, Glenn David will address financial analysts and investors on Thursday, March 13, 2025, at 9:00 AM ET at the Loews Miami Beach Hotel. The live audio presentation will be available on the Phibro Animal Hea...

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Bank of America 2025 Virtual Animal Health Summit. Chief Financial Officer, Glenn David will address financial analysts and investors on Thursday, February 27, 2025, at 10:50 AM ET. The live audio presentation will be available on the Phibro Animal Health Corporation Invest...

Phibro Animal Health delivers animal health and nutritional solutions through feed additives, vaccines, and performance products. The Zoetis acquisition added 37 product lines, driving a 24% increase in net sales and 64% growth in adjusted EBITDA. The company projects strong revenue growth in 2025 with expanding margins and updated EPS guidance.

Phibro Animal Health Corporation (PAHC) Q2 2025 Earnings Call Transcript

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its second quarter ended December 31, 2024, and its updated financial guidance for the year ending June 30, 2025. Highlights for the three months ended December 31, 2024 (compared to the three months ended December 31, 2023) Net sales of $309.3 millio...

TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on March 26, 2025, to stockholders of record at the close of business on March 5, 2025. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a lead...

TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the appointment of Joyce J. Lee, MBA, as a Class II director of the Company, effective immediately. Ms. Lee will be an independent director. Her appointment fills a current vacancy and increases Board membership to nine directors, 6 of whom are independent directors. Ms. Lee...

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its second quarter financial results on Wednesday, February 5, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, February 6, 2025, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation...